FI104255B1 - Method for the preparation of fusion proteins containing N-terminal fragments of human serum albumin - Google Patents
Method for the preparation of fusion proteins containing N-terminal fragments of human serum albuminInfo
- Publication number
- FI104255B1 FI104255B1 FI915073A FI915073A FI104255B1 FI 104255 B1 FI104255 B1 FI 104255B1 FI 915073 A FI915073 A FI 915073A FI 915073 A FI915073 A FI 915073A FI 104255 B1 FI104255 B1 FI 104255B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- fusion proteins
- serum albumin
- human serum
- proteins containing
- Prior art date
Links
- 102000008100 Human Serum Albumin Human genes 0.000 title 1
- 108091006905 Human Serum Albumin Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 210000004898 n-terminal fragment Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8909916 | 1989-04-29 | ||
GB898909916A GB8909916D0 (en) | 1989-04-29 | 1989-04-29 | Polypeptides |
PCT/GB1990/000650 WO1990013653A1 (en) | 1989-04-29 | 1990-04-26 | Fusion proteins containing n-terminal fragments of human serum albumin |
GB9000650 | 1990-04-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI915073A0 FI915073A0 (en) | 1991-10-28 |
FI104255B FI104255B (en) | 1999-12-15 |
FI104255B1 true FI104255B1 (en) | 1999-12-15 |
Family
ID=10656000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI915073A FI104255B1 (en) | 1989-04-29 | 1991-10-28 | Method for the preparation of fusion proteins containing N-terminal fragments of human serum albumin |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0470165A1 (en) |
JP (1) | JP2781459B2 (en) |
KR (1) | KR100227167B1 (en) |
AU (1) | AU630450B2 (en) |
CA (1) | CA2015687C (en) |
FI (1) | FI104255B1 (en) |
GB (2) | GB8909916D0 (en) |
HU (1) | HUT61049A (en) |
IE (1) | IE67651B1 (en) |
IL (1) | IL94243A (en) |
WO (1) | WO1990013653A1 (en) |
ZA (1) | ZA903237B (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
FR2686900B1 (en) * | 1992-01-31 | 1995-07-21 | Rhone Poulenc Rorer Sa | NOVEL POLYPEPTIDES HAVING GRANULOCYTE COLONY STIMULATION ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2686899B1 (en) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
WO1994016085A2 (en) * | 1992-12-30 | 1994-07-21 | Zymogenetics, Inc. | Hybrid proteins having cross-linking and tissue-binding activities |
GB9408466D0 (en) * | 1994-04-27 | 1994-06-22 | Univ Nottingham | Cloning and functional expression of neurotoxins |
US5543308A (en) * | 1994-10-18 | 1996-08-06 | New England Biolabs, Inc. | Isolated DNA encoding the FSEI restriction endonuclease and related methods for producing the same |
US5877149A (en) | 1995-06-07 | 1999-03-02 | Beaulieu; Andre | Deepithelialized skin diffusion cell system |
US5641483A (en) * | 1995-06-07 | 1997-06-24 | Beaulieu; Andre | Wound healing formulations containing human plasma fibronectin |
US6423512B1 (en) | 1996-07-26 | 2002-07-23 | Novartis Ag | Fusion polypeptides |
PE99498A1 (en) * | 1996-07-26 | 1999-01-21 | Novartis Ag | FUSION POLYPEPTIDES |
US5932693A (en) * | 1996-12-10 | 1999-08-03 | Washington University | Antithrombotic peptides |
EP1049790A1 (en) | 1998-01-23 | 2000-11-08 | Novo Nordisk A/S | Process for making desired polypeptides in yeast |
EP1088084B1 (en) | 1998-06-15 | 2006-09-13 | GTC Biotherapeutics, Inc. | Erythropoietin analog-human serum albumin fusion protein |
JP2003530838A (en) * | 2000-04-12 | 2003-10-21 | ヒューマン ゲノム サイエンシズ インコーポレイテッド | Albumin fusion protein |
DE60232083D1 (en) | 2001-08-15 | 2009-06-04 | Takara Bio Inc | EXPANSION CULTURE PROCEDURE FOR ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
CA2471363C (en) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
WO2003080817A1 (en) | 2002-03-25 | 2003-10-02 | Takara Bio Inc. | Process for producing cytotoxic lymphocyte |
KR20060039940A (en) * | 2003-08-22 | 2006-05-09 | 다카라 바이오 가부시키가이샤 | Process for producing cytotoxic lymphocytes |
US7850970B2 (en) | 2003-08-26 | 2010-12-14 | The Regents Of The University Of Colorado | Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
GB0329722D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Modified plasmid and use thereof |
GB0329681D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
DK2330200T3 (en) | 2004-12-23 | 2017-07-24 | Albumedix As | GENE EXPRESSION TECHNIQUE |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
WO2007146038A2 (en) | 2006-06-07 | 2007-12-21 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2007274035A1 (en) | 2006-07-13 | 2008-01-17 | Novozymes Biopharma Dk A/S | Process for preparing particles of proteinaceous material |
EP3243835B1 (en) | 2009-02-11 | 2024-04-10 | Albumedix Ltd | Albumin variants and conjugates |
GB2488077A (en) | 2009-10-30 | 2012-08-15 | Novozymes Biopharma Dk As | Albumin variants |
JP5969458B2 (en) | 2010-04-09 | 2016-08-17 | アルブミディクス アクティーゼルスカブ | Albumin derivatives and variants |
WO2012178102A2 (en) * | 2011-06-24 | 2012-12-27 | The Regents Of The Unversity Of Colorado, A Body Corporate | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
US20140315817A1 (en) | 2011-11-18 | 2014-10-23 | Eleven Biotherapeutics, Inc. | Variant serum albumin with improved half-life and other properties |
MX2014010278A (en) | 2012-03-16 | 2015-03-05 | Novozymes Biopharma Dk As | Albumin variants. |
CA2890766A1 (en) | 2012-11-08 | 2014-05-15 | Novozymes Biopharma Dk A/S | Albumin variants |
WO2014165093A2 (en) | 2013-03-13 | 2014-10-09 | Bristol-Myers Squibb Company | Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto |
AU2016308504A1 (en) | 2015-08-20 | 2018-01-18 | Albumedix Ltd. | Albumin variants and conjugates |
EP3538560A4 (en) * | 2016-11-10 | 2020-06-17 | Keros Therapeutics, Inc. | Gdnf fusion polypeptides and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE459586B (en) * | 1987-09-14 | 1989-07-17 | Mta Szegedi Biolog Koezponti | THE STRUCTURES CODING FOR AUTHENTIC HUMAN SERUM ALBUMIN AND PROCEDURES FOR ITS PREPARATION |
GB8725529D0 (en) * | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
-
1989
- 1989-04-29 GB GB898909916A patent/GB8909916D0/en active Pending
-
1990
- 1990-04-26 AU AU55646/90A patent/AU630450B2/en not_active Expired
- 1990-04-26 WO PCT/GB1990/000650 patent/WO1990013653A1/en active IP Right Grant
- 1990-04-26 JP JP2506978A patent/JP2781459B2/en not_active Expired - Lifetime
- 1990-04-26 EP EP90907285A patent/EP0470165A1/en active Pending
- 1990-04-26 HU HU904413A patent/HUT61049A/en unknown
- 1990-04-27 ZA ZA903237A patent/ZA903237B/en unknown
- 1990-04-27 IE IE155490A patent/IE67651B1/en not_active IP Right Cessation
- 1990-04-27 CA CA002015687A patent/CA2015687C/en not_active Expired - Lifetime
- 1990-04-29 IL IL9424390A patent/IL94243A/en not_active IP Right Cessation
-
1991
- 1991-09-06 GB GB9119043A patent/GB2246783B/en not_active Expired - Lifetime
- 1991-10-14 KR KR1019910701334A patent/KR100227167B1/en not_active IP Right Cessation
- 1991-10-28 FI FI915073A patent/FI104255B1/en active
Also Published As
Publication number | Publication date |
---|---|
KR100227167B1 (en) | 1999-10-15 |
GB2246783B (en) | 1992-10-14 |
GB9119043D0 (en) | 1991-12-04 |
FI104255B (en) | 1999-12-15 |
EP0470165A1 (en) | 1992-02-12 |
AU630450B2 (en) | 1992-10-29 |
ZA903237B (en) | 1991-03-27 |
WO1990013653A1 (en) | 1990-11-15 |
AU5564690A (en) | 1990-11-29 |
IE901554L (en) | 1990-10-29 |
CA2015687C (en) | 2000-08-29 |
GB8909916D0 (en) | 1989-06-14 |
KR920701451A (en) | 1992-08-11 |
IL94243A (en) | 1995-10-31 |
JPH04506598A (en) | 1992-11-19 |
HU904413D0 (en) | 1992-01-28 |
FI915073A0 (en) | 1991-10-28 |
JP2781459B2 (en) | 1998-07-30 |
HUT61049A (en) | 1992-11-30 |
CA2015687A1 (en) | 1990-10-29 |
IL94243A0 (en) | 1991-01-31 |
GB2246783A (en) | 1992-02-12 |
IE67651B1 (en) | 1996-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI104255B1 (en) | Method for the preparation of fusion proteins containing N-terminal fragments of human serum albumin | |
KR100386762B1 (en) | Method of producing recombinant human serum albumin | |
EP0324647A3 (en) | Vector for the expression of fusion proteins and protein immunogens | |
AU626183B2 (en) | Chimaeric hepadnavirus core antigen proteins | |
EP0243929A3 (en) | Polypeptide and protein derivatives and process for their preparation | |
PT86600A (en) | PROCESS FOR THE PREPARATION OF ANTICOAGULANT PEPTIDES | |
FI881743A0 (en) | Method for the preparation of bifunctional proteins | |
PT87688A (en) | HYBRID PROTEIN C AND METHOD FOR ITS PREPARATION | |
DE3788807D1 (en) | FUSION PROTEINS AND PARTICLES. | |
ZA895821B (en) | Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast | |
AU4927390A (en) | Fusion proteins | |
DK203087A (en) | PROCEDURE FOR THE MANUFACTURE OF FUSION PROTEINS AND THE USE OF THE FUSION PROTEIN MANUFACTURED AS A VACCINE | |
PT87207A (en) | PROCESS FOR PREPARING RECOMBINANT HTLV-III PROTEINS AND USES THEREOF | |
AU1216988A (en) | Immunogenic fusion proteins which contain Epstein-Barr virus protein | |
IL94526A0 (en) | Method for c-terminal modification of proteins | |
DK284489A (en) | FUSION PROTEINS | |
DK241688A (en) | PROCEDURE FOR THE MANUFACTURE OF FUSION PROTEINS | |
NO891926L (en) | PROCEDURE FOR THE PREPARATION OF STABLE PROTEIN OR PEPTIDE PREPARATIONS. | |
IL89877A0 (en) | Process for the preparation of proteins which start with n-terminal proline | |
HU895916D0 (en) | Process for the preparation of monoclonal antibody recognaizing reg protein | |
IT8567469A0 (en) | PROCEDURE FOR THE PREPARATION OF N BENZYLOXICARBONS AMINO ACIDS CONTAINING ADDITIONAL FUNCTIONS | |
GB8806571D0 (en) | Supports for proteins & amino acids | |
GB8921227D0 (en) | Antibodies and proteins | |
IE892830L (en) | Fusion protein of paramyxovirus | |
DK362088D0 (en) | FUSION PROTEINS AND FUSION PROTEIN PARTICLES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: NOVOZYMES DELTA LIMITED Free format text: NOVOZYMES DELTA LIMITED |
|
PC | Transfer of assignment of patent |
Owner name: NOVOZYMES BIOPHARMA UK LIMITED Free format text: NOVOZYMES BIOPHARMA UK LIMITED |